Long-term real-world outcomes of first-line immunotherapy in non-small cell lung cancer - a population-based cohort study in Sweden.
Saved in:
| Title: | Long-term real-world outcomes of first-line immunotherapy in non-small cell lung cancer - a population-based cohort study in Sweden. |
|---|---|
| Authors: | Wagenius G; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; Theme Cancer, Medical Unit Head and Neck, Lung, and Skin Tumors, Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden. gunnar.wagenius@regionstockholm.se., Vikström A; Department of Respiratory Medicine, Linköping University Hospital, Linköping, Sweden., Berglund A; Epistat AB, Uppsala, Sweden., Salomonsson S; MSD, Value and Implementation Outcomes Research, Stockholm, Sweden., Bencina G; MSD, Value and Implementation Outcomes Research, Madrid, Spain., Hu X; Merck & Co., Inc., Value and Implementation Outcomes Research, Rahway, New Jersey, USA., Chirovsky D; Merck & Co., Inc., Value and Implementation Outcomes Research, Rahway, New Jersey, USA., Brunnström H; Lund University, Department of Clinical Sciences Lund, Division of Pathology, Lund, Sweden; Department of Genetics, Pathology, and Molecular Diagnostics, Skåne University Hospital, Lund, Sweden. |
| Source: | Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2025 Mar 17; Vol. 64, pp. 415-422. Date of Electronic Publication: 2025 Mar 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
